Goel R, Saini V, Jain S, Gupta A. A review on quality by design approach: Regulatory need. Mintage J Pharma Med Sci 2014; 3(3): 20-6.
Woodcock J. The concept of pharmaceutical quality. American Pharma Rev 2004; 7(6): 1-3.
Asmasiddiqua S, Praven KG, Srujan KM. A challenge to the pharma industry. Int J Innovative Pharma Sci Res 2013; 1(1): 1-22.
Lionberger RA, Lee SL, Lai ML, Raw A, Yu LX. Concepts for ANDAs. American Assoc Pharma Scientists J 2008; 10(2): 268-75.
Gawade A, Chemate S, Kuchekar A. A new approach in product development. J Pharm Pharm Sci 2013; 2(2): 5-10.
Roy S. A holistic concept of building quality in pharmaceuticals. Int J Pharma Biomed Res 2012; 3(2): 100-8.
Trivedi B. QbD in pharmaceuticals. J Pharm Pharm Sci 2011; 4(1): 17-29.
Bhatt D, Rane S. A quantitative approach for pharmaceutical quality by design patterns. Int J Pharm Pharm Sci 2011; 3(1): 1-9.
Purohit PJ, Shah KV. New parameters for quality improvement & pharmaceutical drug development. Int J Pharma Sci 2013; 4(3): 1-17.
Patel H, Parmar S, Patel B. A comprehensive review on quality by design (QbD) in pharmaceuticals. Int J Pharm Sci Rev Res 2013; 21(1): 223-36.
Sangshettia JN, Deshpandea M, Zaheera Z, Shindeb DB, Arote R. Quality by design approach: Regulatory need. Arab J Chem 2017; 10(Suppl. 2): S3412-25.
Kumar VP, Gupta NV. A review on quality by design approach (QBD) for Pharmaceuticals. Int J Drug Dev Res 2015; 7(1): 52-60.
Nasr MM. Implementation of Quality by Design (QbD): Current Perspectives on Opportunities and Challenges- Topic Introduction and ICH Update. Advisory committee for pharmaceutical science and clinical pharmacology. 27 July 2011.
Nasr MM. Pharmaceutical Quality Assessment System (PQAS) in the 21st century. DIA Annual Meeting, Philadelphia, PA, 19 June 2006.
Rathore AS, Low D. Managing raw materials in the QbD paradigm part 2: Risk assessment and communication. Biopharm Int 2010; 23(12): 5.
Robert JL, Ed. Workshop B, Control Strategy: 2010. In: International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use 2010 July 26-28, Luxembourg,
Saini M, Tripathy S, Dureja H. USA FDA’s implementation of QbD and GDUFA: A wakeup call for other regulatory agencies across the globe. J Med Mark 2014; 14(2-3): 108-14.
Patil AS, Pethe AM. Quality by Design (QbD): A new concept for development of quality pharmaceuticals. Int J Pharm Qual Assur 2013; 4(2): 13-9.
Karmarkar S, Garber R, Genchanok Y, George S, Yang X, Hammond R. Quality by design (QbD) based development of a stability indicating HPLC method for drug and impurities. J Chromatogr Sci 2011; 49(6): 439-46.
Cook JA. A technique to estimate in vivo dissolution profiles without data from a solution. The AAPS J 2012; 14(3): 433-6.
Varu RK, Khanna A. A. Opportunities and challenges to
implementing quality by design approach in generic
drug development J Gene Med 2010; 7: 60-73.
Pramod K, Tahir MA, Charoo NA, Ansari SH, Ali J. Pharmaceutical product development: A quality by design approach. Int J Pharm Investig 2016; 6(3): 129-38.
Somma R. Development knowledge can increase manufacturing capacity and facilitate quality by design. J Pharma Innovation 2013; 2(1): 87-92.